EN 
FR 
Linearis with its tandem Ventures Fund and Laboratory is pioneering and supporting discoveries to prevent, detect, and cure metabolic diseases including cancers & diabetes through direct investments in innovative AI-powered life sciences companies.
Metabolomics
Genomics
External
DIAGNOSTIC
monitoring
drug discovery
Accessible Health Through Metabolomic Testing & Drug Discovery
Through the identification of multi-omics disease signatures, we accelerate the innovation cycle in prevention, treatment monitoring and AI drug discovery.
VISION
Accelerate AI innovation to improve people's health with novel Omic-AI tests & facilitate drug discovery.
MISSION
LINEARIS is building a combined omic/AI platform to identify signatures and accelerate drug development, screening and monitoring in metabolomic diseases including cancer, diabetes, and antimicrobial resistance.
VALUES
Innovate Responsibly.
Excel With Rigor.
Foster Integrity And Work Ethics.
Promote Collaborations.
Create Sustainable And Positive
Impacts.
Improve People's Health With
Passion.
